Logotipo del repositorio
Logotipo del repositorio
 

Neuropsychological Performance in Patients with Asymptomatic HIV-1 Infection

Vista sencilla de ítem
dc.contributor.authorMartínez-Banfi, Martha
dc.contributor.authorVélez, Jorge I.
dc.contributor.authorPerea, M. Victoria
dc.contributor.authorGarcía, Ricardo
dc.contributor.authorPuentes-Rozo, Pedro J.
dc.contributor.authorMebarak Chams, Moises
dc.contributor.authorLadera, Valentina
dc.date.accessioned2018-03-02T14:54:22Z
dc.date.available2018-03-02T14:54:22Z
dc.date.issued2018-02-07
dc.description.abstractHuman immunodeficiency virus (HIV-1) infection and acquired immunodeficiency syndrome (AIDS) lead to neurocognitive disorders; however, there is still much knowledge to be gained regarding HIV-associated neurocognitive disorders. The purpose of this study was to assess the cognitive performance, instrumental activities of daily living, depression, and anxiety in patients with asymptomatic HIV-1 infections compared with seronegative participants without neurocognitive impairment. We studied a sample consisted of 60 patients with asymptomatic HIV-1 infections and 60 seronegative participants without neurocognitive impairment from the city of Barranquilla, Colombia, with a mean age of 36.07 years. A protocol of neuropsychological and psychopathological tests was applied to the participants. The group of patients with asymptomatic HIV infections significantly underperformed on tasks that assessed global cognitive screening, attention span, learning, phonemic verbal fluency, auditory-verbal comprehension, information processing speed, cognitive flexibility, and motor skills compared to the group of seronegative participants. No significant differences were found in memory, visual confrontation naming, vocabulary, inhibition, and instrumental activities of daily living. Additionally, the patients with asymptomatic HIV-1 infection had a higher anxiety index than the seronegative participants, but no significant difference was found in depression. A correlation was found between depression and anxiety. In conclusion, the patients with asymptomatic HIV-1 infection had lower cognitive performances than the seronegative participants in the cognitive functions mentioned above and more anxiety but still performed the instrumental activities of daily living.eng
dc.identifier.urihttp://hdl.handle.net/20.500.12442/1755
dc.language.isoengspa
dc.publisherTaylor & Francis Groupspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.sourceRevista AIDS CAREeng
dc.sourceVol. 30, No.5 (2018)spa
dc.source.urihttps://www.tandfonline.com/doi/full/10.1080/09540121.2018.1428728
dc.subjectHuman Immunodeficiency Viruseng
dc.subjectAsymptomaticeng
dc.subjectHIV-associated dementiaeng
dc.subjectNeurocognitive Impairment in HIV-1eng
dc.subjectHIV-associated Neurocognitive Disorderseng
dc.titleNeuropsychological Performance in Patients with Asymptomatic HIV-1 Infectioneng
dc.typearticlespa
dcterms.referencesAbusamra, V., Abusamra, L., Sampedro, B., Difalcis, M., Dávolos, J. M., and Ferreres, A. (2014). Trastornos cognitivos en pacientes VIH-1: la dimensión pragmática de la comunicación verbal. [Cognitive disorders in HIV-1 patients: the pragmatic dimension of verbal communication.] Neuropsicologia Latinoamericana, 6(1), 22-30.eng
dcterms.referencesAcosta-López, JE. Mattar Khalil, SR. Riaño Garzon. ME, Rincón Lozada. CF, Díaz Camargo, EA. (2015). Aportes clínicos al deterioro cognitivo leve (DCL). Revista Fronteras del Saber. 1(7), pp. 56 – 63.spa
dcterms.referencesAntinori, A., Arendt, G., Becker, J., Brew, B. J., Byrd, D., Cherner, M., Wojna, V. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69, 1789 - 1799. doi:10.1212/01.WNL.0000287431.88658.8beng
dcterms.referencesAmador, F., Mayor-Ríos J. and Del Castillo-Martín, N. (2006). Enlentecimiento cognitivo en sujetos seropositivos asintomáticos al virus de inmunodeficiencia humana tipo 1. [Cognitive impairment in seropositive individuals asymptomatic to human immunodeficiency virus type 1.] Revista de Neurología, (42), 129-32.eng
dcterms.referencesArciniegas, Á. Malagón, T., Halliday, K., and Tovar-Cuevas, J. R. (2013). Funciones cognitivas de personas viviendo con VIH/Sida asistentes a un programa de atención integral. [Cognitive functions of people living with HIV/AIDS who are attending a comprehensive care program.] Revista Peruana de Medicina Experimental y Salud Publica, 30(3), 521-530.eng
dcterms.referencesArdila-Ardila, A., Goodkin, K., Concha-Bartolini, M., Lecusay-Ruiz, R., O’Mellan-Fajardo, S., Suárez-Bustamante, P., Wilkie, F. L. (2003). HUMANS: una batería neuropsicológica para la evaluación de pacientes infectados con VIH-1. [HUMANS: a neuropsychological battery for the evaluation of HIV-1-infected patients.] Revista de Neurología, 36(8), 756-762.eng
dcterms.referencesAyuso-Mateos, J. L. (1997). Trastornos neuropsiquiátricos en el SIDA. [Neuropsychiatric disorders in AIDS.] Madrid: McGraw-Hill Interamericana de España.spa
dcterms.referencesBeck, A., Ward, C., Mendelson, M., Mock, J., and Erbaugh, J. (1961). An inventory for measuring depression. Archives of general psychiatry, 4, 561-671.eng
dcterms.referencesBeckford Jarrett, S., De La Haye, W., Miller, Z. Figueroa, JP. Duncan, J. y Harvey, K. (2017). High prevalence of psychiatric and substance use disorders among persons seeking treatment for HIV and other STIs in Jamaica: a short report. AIDS Care, 3:1-5. DOI: 10.1080/09540121.2017.1384786eng
dcterms.referencesBenjamini, Y & Hochberg, Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B. 57 (1): 289–300.eng
dcterms.referencesBernal-Cano, F. (2008). El virus de inmunodeficiencia humana VIH y el sistema nervioso. Principios generales. [The human immunodeficiency virus (HIV) and the nervous system. General principles.] Acta Neurológica Colombiana, 24(3), 124-141.eng
dcterms.referencesBociąga-Jasik, M., Lickiewicz, B., Kalinowska-Nowak Andrzej Cieśla, A., Mach, T., and Garlicki, A. (2010). Neurocognitive disorders in HIV infected patients. HIV and AIDS Review, 9(2), 33-36.eng
dcterms.referencesBornstein, R. A., Fama, R., Rosenberger, P., et al. (1993). Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 5(3), 254-259.eng
dcterms.referencesBragança, M., and Palha, A. (2011). Trastornos neurocognitivos asociados con la infección por el VIH. [HIV-associated neurocognitive disorders.] Actas Españolas de Psiquiatría, 39(6), 374-383.spa
dcterms.referencesBurgess, A. P., Riccio, M., Jadresic, D., Pugh, K., Catalan, J., Hawkins, D. A., Thompson, C. (1994). A longitudinal study of the neuropsychiatric consequences of HIV-1 infection in gay men. Neuropsychological performance and neurological status at baseline and at 12-month follow-up. Psychological medicine, 24(4), 885-889.eng
dcterms.referencesCastro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., y Curran, J. W. (1993). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Clinical Infectious Diseases, 17(4), 802-810.eng
dcterms.referencesChampely, S. (2017). pwr: Basic Functions for Power Analysis. R package version 1.2-1. https://CRAN.R-project.org/package=pwreng
dcterms.referencesCroucher, A. and Winston, A. (2013). Neurological complications of HIV. Medicine, 41:8.eng
dcterms.referencesCustodio, N., Escobar, J., and Altamirano, J. (2006). Demencia asociada a infección por virus de inmunodeficiencia humana tipo 1. [HIV-1-associated dementia.] Anales de la Facultad de Medicina, 67(3), 243-254.eng
dcterms.referencesCysique L.A., Maruff P., Darby D. and Brew B.J. (2006). The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol, 21, (2), 185-94.eng
dcterms.referencesElliott A. Anxiety and HIV infection (1998). STEP Perspect 98(1):11-4.eng
dcterms.referencesEugenin, E. A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T. M., and Berman, J. W. (2006). CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood–brain barrier: a potential mechanism of HIV–CNS invasion and NeuroAIDS. The Journal of neuroscience, 26(4), 1098-1106.eng
dcterms.referencesFaílde, J. M., Lameiras, M., Rodríguez, Y., Carrera, M. V., and López, J. (2009). Características del rendimiento neuropsicológico de pacientes infectados por VIH. [Neuropsychological performance characteristics of HIV-infected patients.] Actas españolas de psiquiatría 37(5), 252-257.spa
dcterms.referencesFolstein, M. F., Folstein, S. E., and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research, 12(3), 189-198eng
dcterms.referencesGalindo-Sainz, J., Rodríguez-Almanza, J. V., Sandoval-Ramírez, J. L., and Tejada-García, R. A. (2010). Prevalencia de alteraciones cognitivas en paciente con VIH-SIDA en una cohorte mexicana. [Prevalence of cognitive disorders in an HIV-AIDS patient in a Mexican cohort.] Medicina Interna de Mexico, 26(2), 116-122spa
dcterms.referencesGhafouri, M., Amini, S., Khalili, K., and Sawaya, B. E. (2006). HIV-1 associated dementia: symptoms and causes. Retrovirology, 3(1), 28.eng
dcterms.referencesGolden, Ch. J. (2005). Test de colores y palabras STROOP. [STROOP color-word test.] (4ª ed.) Madrid: Departamento I+D de TEA Ediciones S. A.spa
dcterms.referencesGroppe, D. M. (2016). Four things you might not (but should know) about false discovery rate control. URL: https://goo.gl/YoY9u9 Accessed November 15, 2017.eng
dcterms.referencesGroppe DM, Urbach TP, Kutas M (2011) Mass univariate analysis of event-related brain potentials/fields I: a critical tutorial review. Psychophysiology 48:1711-25.eng
dcterms.referencesGrupo de Expertos del Grupo de Estudio de Sida (GESIDA) y Secretaría del Plan Nacional sobre el SIDA (SPNS) (2014). [Group of Experts of the Spanish AIDS Study Group (GESIDA) and Secretariat for the National Plan on AIDS (SPNS) (2014).] Documento de consenso sobre el manejo clínico de los trastornos neurocognitivos asociados a la infección por el virus de la inmunodeficiencia humana. [Consensus document on the clinical management of HIV-associated neurocognitive disorders.] Revista de enfermedades infecciosas y microbiología clínica. 32(1):37–47spa
dcterms.referencesGuevara-Silva (2013). Perfil cognitivo en pacientes con infección por el virus de inmunodeficiencia humana neurológicamente asintomáticos. [Cognitive profile in patients with neurologically asymptomatic human immunodeficiency virus infection.] Anales de la Facultad de Medicina, 74(1), 31-6.eng
dcterms.referencesGuevara-Silva, E., Custodio, N., Lira, D., Herrera-Pérez, E., Castro-Suárez, S., Nuñez del Prado, L., and Montesinos, R. (2014). Trastorno neurocognitivo asociado al virus de inmunodeficiencia humana. [HIV-associated neurocognitive disorder.] Anales de la Facultad de Medicina, 75(2), 151-157.spa
dcterms.referencesHabib, A., Yakasai, A., Owolabi, L., Ibrahim, A., Habibi, Z., Gudai, M., Karaye, K., Ibrahim, D. and Nashabaru (2013). Neurocognitive impairment in HIV-1 infected adults in Sub-Saharan Africa: a systematic review and meta-analysis. International Journal of Infectious Deseases 17, e820-e831. http://dx.doi.org/10.1016/j.ijid.2013.06.011eng
dcterms.referencesHalman, M., Chan, S., Stranks, S., Shaefer-McDanields, N. and Stewart, A. (2014). Complex care needs of patients with late-stage HIV disease: A retrospective study. AIDS Care, Vol. 26, 3, 320-355. http://dx.doi.org/10.1080/09540121.2013.819404eng
dcterms.referencesHeaton et al., (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. CHARTER Study.Neurology 75(23), 2087-2096. doi: 10.1212/WNL.0b013e318200d727eng
dcterms.referencesHill, L. y Lee, Kelly (2013). Pharmacotherapy considerations in patients with HIV and psichiatric desorders: Focus on antidepressants and antipsichotic. The Annasl of Pharmacotherapic, 47: 75-89.eng
dcterms.referencesIan, E., et al. (2015). The burden of HIV-associated neurocognitive disorder (HAND) in the Asia-Pacific region and recommendations for screening. Article in press. Asian Journal of psychiatry. http://dx.doi.org/10.1016/j.ajp.2015.10.009eng
dcterms.referencesJessen F., Amariglio RE., van Boxtel M, et al. (2014) A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 10:844-852.eng
dcterms.referencesKalinowska, S., Trześniowska-Drukała, B., and Samochowiec, J. (2013). HIV-associated neurocognitive disorders. Psychiatria Polska, 47(3), 453-463.eng
dcterms.referencesKaplan, E. F., Goddglass, H. and Weintraub, S. (1983). Boston Naming Test. (2ª ed.) Buenos Aires, Argentina: Editorial Médica Panamericana.spa
dcterms.references(Laverick et al., 2017). Self-reported difficulties with everyday function, cognitive symptoms and cognitive function in people with HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes Publish Ahead of Print. DOI: 10.1097/QAI.0000000000001468eng
dcterms.referencesLawton, MP. and Brody, EM. (1969). Assesment of older people: self-maintaining and instrumental activities of daily living. Gerontology, 9(3), 179-86.eng
dcterms.referencesLezak M., Howieson, D. and Loring, D. (1983). Neuropsychological Assesment (2ª ed.). Estados Unidos: Oxford University Press.eng
dcterms.referencesMaj, M., Starace, F., and Sartorius, N. (1991). Neuropsychiatric aspects of HIV-1 infection: data collection instrument for a WHO cross-cultural study. Bull World Health Organ, 69, 243-245.eng
dcterms.referencesManzanera, A. (2014). Trastornos neurocognitivos en personas con VIH +. [Neurocognitive disorders in HIV+ people] MONOGRÁFICO, 1(3), 33-42.spa
dcterms.referencesMarquine MJ, Heaton A, Johnson N, et al. (2017). Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. Journal of the International Neuropsychological Society (2017), 23, 1-13.eng
dcterms.referencesMartin Suarez, I., Cano Monchul, R., Pérez de Ayala, P., Aguayo Canela, M., Cuesta, F., Rodríguez, P., Pujol de la Llave, E. (2002). Calidad de vida, aspectos psicológicos y sociales en pacientes con infección VIH avanzada. [Quality of life, psychological, and social aspects in patients with advanced HIV infection.] Anales de medicina interna, 19, (8).eng
dcterms.referencesMcAllister RH, Herns MV, Harrison MJ, et al. (1992) Neurological and neuropsychological performance in HIV seropositive men without symptoms. J Neurol Neurosurg Psychiatry 55(2):143-8eng
dcterms.referencesMcArthur, J. C., Steiner, J., Sacktor, N. and Nath, A. (2010). Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Annals of Neurology, (6), 699-714. doi: 10.1002/ana.22053eng
dcterms.referencesMehta P, Gulevich SJ, Thal LJ, et al. (1996) Neurological Symptoms, Not Signs, Common in Early HIV Infection. J NeuroAIDS 1(2):67-85.eng
dcterms.referencesMillana-Cuevas, L. C., and Portellano, J. A. (2000). Evaluación Neuropsicológica de los déficit cognitivos en la infección por el virus de la inmunodeficiencia humana tipo 1 (VIH-1). [Neuropsychological assessment of cognitive deficits in human immunodeficiency virus type 1 (HIV-1) infection.] Revista de Neurología, 31(12), 1192-1201.eng
dcterms.referencesMinisterio de Salud y Protección Social y Fondo de población de las Naciones Unidas (2014). Guía de práctica clínica (GPC) basada en la evidencia científica para la atención de la infección por VIH/SIDA (con 13 años o más edad) y adultos. GPC-2014-39. Bogotá, Colombia.spa
dcterms.referencesONUSIDA (2015a). Estimaciones sobre el VIH y el SIDA. [Estimates of HIV and AIDS.] Retrieved from: http://www.unaids.org/es/regionscountries/countries/colombiaeng
dcterms.referencesONUSIDA (2015b). Estadísticas globales. [Global statistics.] Retrieved from: Hoja informativa 2015. [Fact sheet 2015] http://www.unaids.org/sites/default/files/media_asset/20150901_FactSheet_2015_es.pdfeng
dcterms.referencesOtrosky-Solis, F., Ardila, A. and Rosselli, M. (1999). Evaluación Neuropsicológica breve en español (Neuropsi). [Brief Neuropsychological Assessment in Spanish (Neuropsi).] Mexico: Publingenio, S.A.eng
dcterms.referencesParry, S., Zetler, S., Kentridge, A., Petrak, J. and Barber, T. (2017). Simple screening for neurocognitive impairment in routine HIV outpatient care: is it deliverable? AIDS Care, 14: 1-5 doi: 10.1080/09540121.2017.1300632.eng
dcterms.referencesPaul, R., Cohen, R., Navia, B. and Tashima, K. (2002). Relationship between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neuroscience and Biobehavioral Reviews, (26), 353-359.eng
dcterms.referencesPerdices M, Dunbar N, Grunseit A, et al. (1992) HIV related symptomatology across the spectrum of HIV disease. Aust N Z J Psychiatry 26(4):560-6.eng
dcterms.referencesPino-Melgarejo, M. and Omar-Martínez, E. (2014). Cognición y VIH. Algunas consideraciones. [Cognition and HIV. Some thoughts.] Santiago (135), 664-674.spa
dcterms.referencesPortellanos, J. (2005). Introducción a la Neuropsicología. [Introduction to Neuropsychology.] España: McGraw-Hill.spa
dcterms.referencesPumpradit W, Ananworanich J, Lolak S, et al. (2010) Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. J Neurovirol 16(1):76-82.eng
dcterms.referencesRackstraw, S. (2011). HIV-related neurocognitive impairment–A review. Psychology, Health and Medicine, 16(5), 548-563.eng
dcterms.referencesRey, A. (1964). L’examen clinique en psychologie. Paris: Presses Universitaires de France.eng
dcterms.referencesRey, A. (2003). Test de copia y de reproducción de memoria de figuras geométricas complejas. [Rey-Osterrieth Complex Figure Test.] (8ª ed.). Madrid: TEA Ediciones. [TEA Publishers].eng
dcterms.referencesRobertson, K., Bayon, C., Molina, J., et al. (2014). Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. AIDS Care, Vol. 26, No. 12, 1555-1561. http://dx.doi.org/10.1080/09540121.2014.936813eng
dcterms.referencesSalawu, F. K., Bwala, S. A., Wakil, M. A., Bani, B., Bukbuk, D. N., and Kida, I. (2008). Cognitive function in HIV-seropositive Nigerians without AIDS. Journal of the neurological sciences, 267(1), 142-146.eng
dcterms.referencesSánchez-Fernández, M., y Tomateo-Torvisco, D. (2014). Síndromes psiquiátricos en personas infectadas con el Virus de la Inmunodeficiencia Humana: una revisión breve. Revista de Neuro-Psiquiatría, 77(2), 70-77.spa
dcterms.referencesSelnes, O. A., and Miller, E. N. (1994). Development of a screening battery for HIV-related cognitive impairment: The MACS experience. In I. Grant and A. Martin (Eds.), Neuropsychology of HIV infection (pp. 176). USA: Oxford University Press.eng
dcterms.referencesSchmidt, M. (1996). Rey Auditory and Verval Learning Test: A handbook. Los Angeles, CA: Western Psychological Services.eng
dcterms.referencesSherr, L., Cluclas, C., Harding, R., Sibley, E. and Catalan, J. (2011). HIV and Depression – a systematic review of interventions. Psychology, Health & Medicine, (16) 5, 493–527.eng
dcterms.referencesSpielberger, C. D. and Díaz-Guerrero (1975). IDARE. Inventario de Ansiedad: Rasgo-Estado. Manual e Instructivo. [Trait-State Anxiety Inventory. Manual and Instruction.] Mexico: Manual Moderno. [Modern Manual.]spa
dcterms.referencesSpreen, O. and Strauss, E. (1998). A compendium of neuropsychological tests. (2ª ed.) New York: Oxford University.eng
dcterms.referencesStorey, J. D., & Tibshirani, R. (2003). Statistical significance for genomewide studies. Proc Natl Acad Sci U S A, 100(16), 9440-9445.eng
dcterms.referencesTowgood, K. J., Pitkanen, M., Kulasegaram, R., Fradera, A., Kumar, A., Soni, S., . . . Kopelman, M. D. (2012). Mapping the brain in younger and older asymptomatic HIV-1 men: Frontal volume changes in the absence of other cortical or diffusion tensor abnormalities. Cortex, 48(2), 230-241.eng
dcterms.referencesVance, D., Randazza, J., Fogger, S., Slater, L., Humphrey, S., and Keltener, N. (2014). An overview of the biological and psychosocial context surrounding neurocognition in HIV. Journal of the American Psychiatric, Nurses Association, 20(2), 117-124. Doi: 10.1177/1078390314527549.eng
dcterms.referencesVera-Villaroel, P., Pérez, V., Moreno, E., and Allen de F. (2004). Diferencias en variables psicosociales en sujetos VIH homosexuales y heterosexuales. [Differences in psychosocial variables in homosexual and heterosexual HIV subjects.] Internacional Journal of Clinical and Health Psychology, 4, 55-67.eng
dcterms.referencesVally, Z. (2011). HIV-associated neurocognitive disorders. South African Journal of Psychiatry, 17(4), 98-102.eng
dcterms.referencesVenier, A., Murillo, P., Godoy, J. (2012). Evaluación de las Funciones Ejecutivas en Personas con VIH Asintomático. [Assessment of Executive Functions in People with Asymptomatic HIV.] Revista Neuropsicología, Neuropsiquiatría y Neurociencias, 12, (2), 129-141 129 ISSN: 0124-126spa
dcterms.referencesVélez JI, Correa JC, Arcos-Burgos M (2014) A new method for detecting significant p-values with applications to genetic data. Revista Colombiana de Estadistica 37:67-76.eng
dcterms.referencesVélez, J.I., Lopera,F., Sepulveda-Falla, D., et al. (2016). APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease. Mol Psychiatry. 21(7):916-24. doi: 10.1038/mp.2015.177eng
dcterms.referencesVergara E., García A., García M. and Vergara A. (2010). Alteraciones neurocognitivas asociadas al virus de la inmunodeficiencia humana en pacientes marginales con trastornos por consumo de sustancias. [HIV-associated neurocognitive disorders in marginal patients with substance use disorders.] Revista Alzheimer, (46), 37-43.spa
dcterms.referencesVillaseñor-Cabrera, T., and Rizo-Curiel, G. (2003). Trastornos cognoscitivos asociados al efecto del VIH/sida en el cerebro. Estudio comparativo entre los estadios inicial y final. [Cognitive disorders associated with the effect of HIV/AIDS on the brain. Comparative study between the initial and final stages.] Investigación en Salud, 5(3), 146-153.spa
dcterms.referencesWeber E, Blackstone K, Woods SP (2013). Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev. 23(1):81-98. doi: 10.1007/s11065-013-9225-6.eng
dcterms.referencesWechsler, D. (2001). Manual de aplicación y corrección de la escala de inteligencia de Wechsler (WAIS-III). [Wechsler Intelligence Scale Application and Correction Manual (WAIS-III).] Madrid: TEA Ediciones. [TEA Publishers].spa
dcterms.referencesWechsler, D. (2004). Escala de memoria de Wechsler-III. [Wechsler memory scale-III.] Madrid: TEA Ediciones.spa
dcterms.referencesWhite, D. A., Heaton, R. K., Monsch, A. U. and The HNRC Group (1995). Neuropsychological studies of asymptomatic human immunodeficiency virus type-1 infected individuals. Journal of the International Neuropsychological Society, (1), 304-315.eng
dcterms.referencesWilkie, F. L., Eisdorder, C., Morgan, R. Loewenstein, D. A. and Szapocznick, J. (1990). Cognition in early human immunodeficiency virus infection. Archives of Neurology, (47), 433-440.eng
dcterms.referencesWoods, S. P., Moore, D. J., Weber, E., and Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology review, 19(2), 152-168.eng

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
PDF.pdf
Tamaño:
538.11 KB
Formato:
Adobe Portable Document Format
Descripción:
Formato Pdf texto completo
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos

Universidad Simón Bolívar: Todos los derechos reservados / Sistema de biblioteca